Poseida Therapeutics, Inc. today announced that the Company will participate in the following upcoming investor conferences.
SAN DIEGO, Nov. 8, 2022 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced that the Company will participate in the following upcoming investor conferences: Stifel 2022 Healthcare Conference Piper Sandler 34th Annual Healthcare Conference Webcasts will be available on the Investors & Media Section of the Poseida website, www.poseida.com. A replay of each webcast will be available for approximately 90 days following each presentation. About Poseida Therapeutics, Inc. View original content to download multimedia:https://www.prnewswire.com/news-releases/poseida-therapeutics-to-present-at-two-upcoming-investor-conferences-301670922.html SOURCE Poseida Therapeutics, Inc. | ||
Company Codes: NASDAQ-NMS:PSTX |